Unmissable Buying Opportunity: Barclays Reveals Strong Potential in Orthodontics Stock Amid U.S.-Iran War!
Barclays has reassessed Align Technology’s market position in light of recent tensions in the Middle East, upgrading its rating from equal weight to overweight. This decision reflects a favorable shift in the risk-reward profile for the orthodontics company, according to analyst Glen Santangelo. With a price target of $200, Barclays suggests that Align’s stock could rise by 18% from its closing price on Monday.
Earlier this year, Align’s shares reached $197 after the company reported strong fourth-quarter results and laid out optimistic guidance for fiscal 2026. However, the stock has since experienced a pullback influenced by broader market trends. “The Middle East conflict has triggered a 15% pullback from the recent February high, improving the risk/reward,” Santangelo explained. He acknowledged the possibility that ongoing conflict could render their forecast premature, yet remains bullish — especially as Align is currently trading at 10 times EBITDA.
Santangelo highlighted the robust performance of Align in its fourth-quarter results, noting a resurgence in business momentum across various segments and geographic markets. He pointed to increased website traffic to Align’s homepage and My Invisalign page as evidence that the positive trends observed last quarter are continuing. “We are encouraged by the continued strength of the data, particularly as consensus has revenues modeled down 2.4% sequentially from Q4 to Q1,” he remarked.
It’s worth noting that Align’s exposure to the Middle Eastern market is minimal, reported to be in the single-digit range, and the company operates a manufacturing facility in Israel. As of the most recent updates, this facility remains operational and untouched by the ongoing strife. While Santangelo indicated that, to date, there has been no significant impact on Align’s financial outlook due to the conflict, he emphasized the fluid nature of the situation.
Through these insights, Barclays positions Align Technology as a valuable investment opportunity in a challenging climate. The combination of recent financial results and the operational stability of its facilities suggest that Align may be well-positioned to capitalize once market conditions stabilize.
As investors navigate through turbulent waters, they may want to consider Align Technology’s potential for growth amid changing market dynamics. With a promising outlook from Barclays, the stock could be an appealing option for those looking to enhance their portfolios in the orthodontics sector.
Categories: Business, Stock Market, Investment
Tags: Align Technology, Barclays, Glen Santangelo, stock upgrade, orthodontics, Middle East conflict, investment strategy.
Original Source: https://www.cnbc.com/2026/03/17/a-buying-opportunity-in-this-orthodontics-stock-has-emerged-amid-us-iran-war-says-barclays.html
Category :
Tags:
Publish Date: 2026-03-17 16:22:00
